Procedure safety
In an early clinical study of patients with heart
failure, the procedure was successful at creating
a pathway in 100% of patients. There were no
procedure or device related adverse events
reported through one year of follow-up.3
Improved quality
of life
Participants experienced an improvement in their quality of life and did not require hospitalization for heart failure throughout one year of follow up.3
Walk further,
feel stronger
Study participants experienced consistent improvement in how far they could walk following the procedure through one year.3
Caution - Investigational device. Limited by Federal (or United States) law to investigational use.
3. EASE HF 1 Year Clinical Study Data Report on file at InterShunt Technologies, Inc.